FDA Import Refusal 799-0755131-3/10002/2 — RADIANT PHARMACEUTICALS LTD.
The FDA refused shipment 799-0755131-3/10002/2 from RADIANT PHARMACEUTICALS LTD. (India) on Sep 3, 2025. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Sep 3, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDB49 NAPROXEN (ANTI-INFLAMMATORY)
- Charges
- 75